Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 and Venous Thromboembolism Risk

NCT04569344 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT04569344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04569344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 and Venous Thromboembolism Risk
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Completed
Start date
January 1, 2020
Completion date
June 21, 2022
Enrollment
Not reported
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, venous thromboembolism